Vaxess lays out path to the clinic for its silk-derived, drug-dispersing patch

//Vaxess lays out path to the clinic for its silk-derived, drug-dispersing patch

Vaxess lays out path to the clinic for its silk-derived, drug-dispersing patch

The Cambridge-based biotech has spent the last seven years developing a patch it hopes will disperse everything from vaccines to cancer treatments through roughly 120 microscopic needles made from silk proteins.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-06-27T10:33:10+00:00 June 27th, 2019|Healthcare|

About the Author: